Please use this identifier to cite or link to this item:
Title: Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII survey.
Authors: Argüelles Arias, Federico
Barreiro-de Acosta, Manuel
Hinojosa, Joaquín
metadata.dc.subject.mesh: Drug Costs
Health Care Surveys
Inflammatory Bowel Diseases
Issue Date: 2016
Abstract: Inflammatory bowel disease (IBD) units have a relevant weight within gastroenterology departments. In order to gain insight into the managerial aspects of IBD diagnosis and treatment, SEPD submitted a survey (GESTIONAEII) to department heads, IBD specialists, and other gastroenterologists. In this letter, we discuss the results obtained from gastroenterology department heads.
metadata.dc.identifier.doi: 10.17235/reed.2016.4192/2016
ISSN: 1130-0108
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.